Bullous pemphigoid is an autoimmune subepidermal blistering disorder that typically affects elderly adults but can also occur in childhood. We report on a 3-month-old boy who developed bullous pemphigoid 1 week after the second routine administration of a hexavalent vaccine. The disease was resistant to standard therapies (including oral and topical corticosteroids) but was relieved by intravenous immunoglobulin treatment. There was no recurrence of bullous pemphigoid after the next vaccination (3 mos after discontinuation of steroids).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/pde.12360 | DOI Listing |
Publication Analysis
Top Keywords
bullous pemphigoid
16
intravenous immunoglobulin
8
postvaccinal corticosteroid-resistant
4
bullous
4
corticosteroid-resistant bullous
4
pemphigoid
4
pemphigoid infancy
4
infancy treatment
4
treatment intravenous
4
immunoglobulin bullous
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!